Document:

<PAGE>
                                                                   EXHIBIT 10.12

                      PATENT LICENSE AND ROYALTY AGREEMENT

     THIS AGREEMENT (the "Agreement") is made by and between OccuLogix, Inc.
(formerly Vascular Sciences Corporation), a Delaware Corporation (the
"Licensee"), and Dr. Hans Stock ("Stock") living in Germany, and the assignee of
the rights of Prof. Dr. Helmut Borberg ("Borberg"), listed as inventor along
with Dr. Richard Brunner ("Brunner") in US patent application 09/000,917, which
is the parent application of US letters patent 6,245,038 issued June 12, 2001
(the "Patent").

     WHEREAS, Brunner executed a patent license and royalty agreement with a
predecessor of the Licensee as of May 6, 2002 and amended and restated that
agreement as of the date hereof;

     WHEREAS, Borberg assigned all his right, title and interest to the Patent
and the Patent Rights to Stock;

     WHEREAS, Stock originally licensed any and all of his rights, title and
interests to the Patent and the Patent Rights to the Licensee in an undocumented
oral agreement;

     WHEREAS, Stock continues to desire to license any and all of his rights,
title and interest to the Patent and the Patent Rights derived therefrom to
Licensee, and

     WHEREAS, Licensee continues to desire to obtain an exclusive license to all
of Stock's interest in the Patent and the Patent Rights derived therefrom and to
exclusively own the License to any and all of his rights, title, interests and
ownership to the Patent and any and all related patents, rights and inventions
that specifically relate to the Patent whether owned now or at any time in the
future by Stock (the "License"), and

     WHEREAS, Stock shall be eligible to receive any and all consideration and
compensation from the Licensee, such as those pledged to be made by the Licensee
to Stock under the terms of this Agreement.

     NOW THEREFORE, in consideration for guaranteed Advance Royalty Payments and
Royalty Payments as described below, and other good and valuable consideration,
Stock does hereby continue to exclusively license, in accordance with the terms
set forth below, unto Licensee, its successors and assigns, Stock's entire
undivided right, title, ownership and interest in and to the Patent and the
invention(s) therein contained (the "Patent Rights"), throughout the Territory,
to be held and enjoyed by Licensee its successors and assigns, the same as it
would have been held and enjoyed by Stock if this Patent License and Royalty
Agreement had not been made and entered into.

     Stock recognizes that by signing this Agreement, the combination of this
Agreement and a patent license and royalty agreement between Brunner and
Licensee will collectively constitute an EXCLUSIVE PATENT LICENSE AND ROYALTY
AGREEMENT by which Stock and Brunner grant an exclusive license in the patent to
Licensee including the right to sue for past infringement.
<PAGE>
                                      -2-

1.  Patent Rights. Shall mean any and all of Stock's rights, title, ownership
    and interests in and to US letters patent 6,245,038 and any and all
    inventions, modifications, continuations-in-part, extensions, divisions,
    improvements, etc. made by Stock or his agents, in any and all areas that
    relate directly to the Patent, regardless of whether such inventions or
    improvements are patentable or may become patented; all inventions,
    modifications, continuations-in-part, extensions, divisions, improvements,
    etc. shall automatically be incorporated herein without the payment of any
    additional fees, royalties or any other compensation or considerations of
    any kind.

2.  Representation by Stock. Stock warrants that he as the assignee of the
    right of Borberg, along with Brunner, as the joint inventors of United
    States Patent 6,245,038, exclusively owns and possesses the Patent and the
    Patent Rights, and has all right and title thereto and that this Patent
    License and Royalty Agreement is made without encumbrance or threat of
    future interference by others claiming ownership therein and that no
    security interests to any third party exists therein or any other agreement
    the contrary.

3.  Representation by Licensee. Licensee represents that it is a bona fide
    corporation in good standing in Delaware.

4.  Advance Royalty Payments. Licensee agrees to pay Stock Fifty Thousand
    Dollars ($50,000 USD) annually as an advance and credited against any and
    all Royalty Payments paid in accordance with this Agreement. Such Advance
    Royalty Payments shall be paid to Stock and in equal payments of Twelve
    Thousand Five-hundred Dollars ($12,500 USD), made quarterly, on or before
    the expiration of Forty-five (45) days after the reporting close of each
    prior calendar quarter.

5.  Royalty Payments. Licensee agrees to pay royalties to Stock totaling
    One-and-a-Half Percent (1.5% in USD). Royalty Payments shall be calculated
    and paid based upon Total Net Revenues that Licensee receives from the bona
    fide commercial sales of its Products sold in reliance and dependence upon
    the validity of the Patient's claims and of the Patent Rights in the
    Territory.

6.  Accounting and Timing of Royalty Payments. Upon making each Royalty Payment,
    Licensee shall provide Stock with a summary of the accounting used to
    determine the amount of Royalty Payment due. Royalty Payments shall be made
    by wire transfer and shall be computed on Total Net Revenues received by the
    Licensee by the reporting close of each calendar quarter and distributed and
    paid to Stock and on a quarterly basis, on or before the expiration of
    Forty-five (45) days after the reporting close of each prior calendar
    quarter.

7.  Failure to Pay by Licensee. Should Licensee fail to make any payments as
    required herein, and should the Licensee fail to cure the breach created
    thereby, any and all rights, title and ownership to the License provided to
    the Licensee under this Agreement shall be forfeited and any and all such
    rights, title and ownership to the License shall, upon notice of the
    failure to cure the breach, immediately revert to Stock, and all monies paid
    by Licensee until such date shall be retained by him without forfeiture.
<PAGE>

                                     - 3 -

8.   Territory. Shall mean the United States and any other jurisdictions subject
     to recognizing any valid claims of the Patent or of the Patent Rights.

9.   Total Net Revenues. Shall mean total gross revenues less any discounts,
     rebates, shipping costs, handling costs, transportation insurance costs,
     importation fees, and duties on any and all Products sold by the Licensee
     in the Territory and which are sold in reliance upon and specifically used
     in accordance with or subject to any of the valid claims of the Patent.

10.  Records. Licensee agrees to keep complete and correct books, accounts and
     records according to Generally Accepted Accounting Principles (GAAP)
     regulations to facilitate computation of Royalty Payments. Stock or his
     representatives acceptable to Licensee, shall have a full right of
     accounting including the right to confidentially examine Licensee's books
     and records, at all reasonable times and upon reasonable notice, for the
     purpose of verifying the amount of Royalty Payments due.

11.  Products. Shall mean any of Licensee's products, goods or technologies sold
     unaffiliated third parties in the Territory for the purposes of providing
     extracorporeal therapies for the treatment of the ophthalmic diseases as
     defined by any valid claim(s) of the Patent, in this case, Licensee's sale
     of extracorporeal filters and tubing sets for use in any and all ophthalmic
     indications.

12.  Term. The Royalty Payments shall be due to Stock beginning with the first
     bona fide commercial sale of any Product in the Territory and may, at the
     discretion of Licensee terminate upon the first of any of the following
     three events to occur. (a) All patents of the Patent Rights expire; (b) All
     patent claims of the Patent Rights are invalidated; or (c) A similarly
     fashioned competitive extracorporeal product, method or technology is
     commercially introduced in the Territory for use in ophthalmic indications
     that could not be deterred by best-efforts enforcement/infringement
     proceedings brought by Licensee against the competitive product, method or
     technology where such proceedings are made in reliance in full or in part
     upon the Patent's claims and or the Patent Rights.

13.  Patent Defense. Licensee shall pay for any and all costs incurred for
     patent maintenance, enforcement and defense of the Patent or the Patent
     Rights in the Territory.

14.  Participation. Stock agrees, in consideration of the premises herein, that
     his executors and administrators will, at any time upon request,
     communicate to the Licensee, its successors and assigns, any facts relating
     to said Patent and Patent Rights, and the history thereof, known to him or
     his successors and assigns, and that he will testify as to the same in any
     interference or other proceeding when requested to do so by the Licensee,
     its successors and assigns. Any and all costs of such participation by
     Stock or his successors and assigns shall be borne by Licensee.

15.  Succession. Stock binds himself and his heirs, executors, administrators,
     employees and legal representatives, as the case may be, to execute and
     deliver to the Licensee, its successors and assigns, any further documents
     or instruments and to do any and all further acts that may be deemed
     necessary by the Licensee, its successors and assigns to
<PAGE>
                                      -4-

    file applications for improvements and inventions in any country where
    Licensee may elect to file such application(s), and that may be necessary
    to vest in the Licensee, its successors and assigns, the license, rights or
    title herein conveyed, or intended so to be, and to enable such title to be
    recorded in the United States and or foreign countries where such
    application(s) may be filed. Any and all costs of such participation by
    Stock or his successors and assigns shall be borne by Licensee.

16. Relationship of the Parties: Indemnification. It is agreed that this
    Agreement does not make any Party herein a general or special agent, legal
    representative, subsidiary, joint venturer, partner, employee or servant of
    any other Party herein for any purpose.

17. Breach and Disputes. Any breaching Party shall have Thirty (30) Days from
    the date of notification to cure such breach. Any dispute between the
    Parties to this Agreement shall be resolved through binding arbitration,
    which shall be governed under the rules and regulations of the American
    Arbitration Association.

18. Forum, Venue and Governing Law. This agreement shall be governed and
    interpreted under Delaware law (without applying its conflict of law
    principles). Exclusive venue for legal proceedings arising hereunder shall
    be in Hillborough County, Florida.

19. Entire Agreement. This Agreement supersedes any prior understanding that
    may have been reached between the Parties (including the Consulting
    Agreement between OccuLogix Corporation and Hans Stock dated June 25, 2002)
    and encompasses the entire agreement between the Licensee and Stock with
    respect to the Patent and the Patent Rights. The terms of this Agreement are
    confidential and shall be maintained by the Parties in accordance thereby.

20. Modification. This Agreement cannot be modified except in writing executed
    mutually between the Parties.

          IN WITNESS WHEREOF, the Parties have signed and executed this
Agreement and have caused this Agreement to becomes effective as of the
Effective Date last executed below.

OCCULOGIX, INC.                                Dr. HANS STOCK

By:__________________________                  By: /s/ Dr. Hans Stock
                                                  --------------------
Title:_______________________

Date:________________________                  Date: 6. August 2004EXHIBIT 10.63  

THE NEPTUNE SOCIETY,
INC. 

DEBENTURE PURCHASE
AGREEMENT 

        This
Debenture Purchase Agreement (this “Agreement”) is dated June 18, 2004 by and
between The Neptune Society, Inc., a Florida corporation (the “Corporation”) and
Brooklyn Holdings LLC, a Nevis limited liability company (“Holder”). The
Corporation and Holder are collectively referred to herein as the “parties” and
each a “party.” 

        NOW,
THEREFORE, in consideration of the above and the mutual promises hereinafter set forth,
the parties hereto agree as follows: 

1.
     AGREEMENT TO SELL AND PURCHASE 

        1.1
    Sale and Purchase. Subject to the terms and conditions hereof, at the Closing (as
defined in Article 3 below), the Corporation hereby agrees to issue and sell to Holder,
and Holder agrees to purchase from the Corporation, a convertible secured debenture (the
“Debenture”), due June 18, 2014, in the principal amount of Six Million Dollars
($6,000,000) (the “Principal Amount”). 

        1.2
    Debenture. The purchase price for the Debenture shall be equal to 100% of the
Principal Amount (the “Purchase Price”). The Debenture to be in the form of the
Debenture attached hereto as Exhibit A and to be convertible (subject to terms,
conditions and adjustments set forth therein) into shares of common stock of the
Corporation (“Common Stock”) as set forth therein. 

2.     COMMITMENT FEE 

        2.1
    Fee. At Closing, the Corporation will issue to the Holder, as a commitment fee in
consideration of entering into this Agreement and agreeing to the terms and conditions set
forth the Debentures, a total of two hundred and fifty thousand (250,000) shares of Common
Stock (the “Consideration Shares”). 

        2.2
    Registration of Consideration Shares. Within sixty (60) days of Closing, the
Corporation, at the Corporation’s sole expense, shall use commercially reasonable
efforts to file with the United States Securities and Exchange Commission (the
“SEC”) a registration statement under the Securities Act of 1933, as amended
(the “Securities Act”), on Form S-1 or, if available, Form SB-2 or Form S-3, or
any similar or successor form, to register the resale of the Consideration Shares, which
are not then registered under the Securities Act or are not otherwise tradable without
restriction under Rule 144(k) of the Securities Act; provided however that the
Holder may waive the requirement that the Corporation file a registration statement with
respect to the Consideration Shares within sixty (60) days of Closing and thereafter shall
have the right to cause the Corporation to file such a registration statement upon thirty
(30) days notice to the Corporation. The Corporation shall use reasonable commercial
efforts to cause such registration statement to be declared effective within ninety (90)
days of filing a registration statement under this Section 2.2, unless the Chief Executive
Officer of the Corporation provides Holder with a certificate certifying that the
reason(s) the registration statement was not effective was due to factors reasonably
beyond the Corporation’s control. The Corporation shall use its best efforts to 

1 

keep the Registration Statement
continuously effective until the date on which all Consideration Shares covered by such
Registration Statement have been sold or may be sold under Rule 144 or another applicable
exemption under the Securities Act. In connection with the foregoing, the Corporation
shall promptly file with the SEC such amendments to a registration statement as may be
necessary to keep such registration statement effective. The Corporation shall bear all
reasonable expenses incurred in connection with the registration of Consideration Shares
pursuant to this Section 2.2., including all printing, legal and accounting expenses
incurred by the Corporation and all registration and filing fees. It shall be a condition
precedent to the obligations of the Corporation to take any action pursuant to this
Section 2.2 that the Holder shall furnish to the Corporation such information regarding
themselves, the Consideration Shares held by them and the intended method of disposition
of such securities as shall be reasonably required to effect the registration of their
Consideration Shares and to execute such documents in connection with such registration as
the Corporation may reasonably request. The Holder shall be responsible for its legal and
accounting expenses and all brokerage commissions and taxes of any kind (including,
without limitation, transfer taxes) with respect to any disposition, sale or transfer of
Consideration Shares. 

3.     CLOSING; CONDITIONS TO CLOSING 

        3.1
    The closing of the transactions contemplated under this Agreement (the
“Closing”) shall take place at such place as the Corporation and Holder may
mutually agree on June 18, 2004 or such other date as the Corporation and Holder may
mutually agree (the “Closing Date”). 

        3.2
    At, or prior to the Closing, upon and in consideration of the transactions contemplated
under this Agreement, the Parties agree as follows: 

                (a)     The
Corporation shall have furnished to Holder, in form satisfactory to Holder,           a
payoff statement executed by CapEx, L.P. (“CapEx”) and Bow River
          Capital Partners, LLC (“Bow River”) (i) setting forth the full amount
          necessary to pay off any and all debts owing to CapEx and Bow River as of the
          Closing Date (the “CapEx Obligation”); and (ii) containing a full
          release of any and all liens and other security interests CapEx and Bow River
          may have in any of the assets, including real and personal property, of the
          Corporation and Neptune Society of America, Inc., a California corporation,
          Neptune Management Corp., a California corporation, Heritage Alternatives,
Inc.,           a California corporation and Trident Society, Inc., a California
corporation           (collectively, the “Subsidiaries”), and any and all other
claims on or           interests in the Corporation and the Subsidiaries which CapEx and
Bow River may           have as a result of or in connection with the CapEx Obligation or
other           obligations, excepting CapEx’s and Bow River’s equity interests
in           common shares of the Corporation;  

     
                
(b)     
          the Corporation will have repaid in full the CapEx Obligation; 

     
                
(c)     the Corporation will execute and deliver to Holder the Debenture; 

     
                
(d)     (i) the Corporation and the Subsidiaries will execute and deliver to Holder the
          Security Agreements (as defined in the Debenture and hereinafter referred to as
          the “Security 

2 

Agreements”)              and
(i) the Subsidiaries will execute and deliver to Holder the Guarantees (as
          defined in the Debenture and hereinafter referred to as the           “Guarantees”);  

     
                
(e)     Holder shall wire the amount of Six Million Dollars (US $6,000,000) less the
          Corporation’s reimbursement of Holder’s legal fees and costs incurred
          in connection with this transaction in accordance with the provisions of Article
          8 below (the “Escrow Funds”) into escrow to be held by Brent Lokash
          Law Corporation, as escrow agent (the “Escrow Agent”) and shall have
          instructed Escrow Agent to release the Escrow Funds to the Corporation upon the
          Closing, such funds to represent Holder’s funding of the Principal Amount; 

     
                
(f)     The Corporation shall have complied with all of its covenants and agreements
          contained in this Agreement and all representations and warranties of the
          Corporation contained in this Agreement shall be true; 

     
                
(g)     The Corporation shall have furnished to Holder in form satisfactory to Holder
          executed authorizations by the Board of Directors of the Corporation and the
          Subsidiaries approving and authorizing the transactions contemplated by this
          Agreement; 

     
                
(h)     The Corporation shall have furnished to Holder in form satisfactory to Holder
          executed officers’ certificates of the Corporation and the Subsidiaries in
          connection with the transactions contemplated by this Agreement; and 

     
                
(i)     Holder shall have received an opinion of counsel for the Corporation and the
          Subsidiaries in form and substance reasonably acceptable to the Holder in
          connection with the transactions contemplated by this Agreement. 

4.     REPRESENTATIONS AND WARRANTIES OF THE CORPORATION 

        The
Corporation hereby represents and warrants to Holder, subject to such exceptions as are
specifically disclosed in writing in the disclosure letter supplied by Corporation to
Holder dated as of the date hereof (the “Disclosure Schedule”, it being
acknowledged that disclosure in the Disclosure Schedule with respect to any particular
Section of this Agreement shall be deemed disclosure with respect to each other Section of
this Agreement if the applicability of such disclosure to the subject matter of such other
Section is reasonably clear on its face), as of the Closing Date: 

        4.1
    Organization, Subsidiaries, Good Standing, Qualification and Power and Authority.
The Corporation is a corporation duly organized, validly existing and in good standing
under the laws of the State of Florida. The Corporation and each of the Subsidiaries have
all requisite corporate power and authority to (a) execute and deliver this Agreement, the
Debenture, the Guarantees, the Security Agreements and the other agreements, instruments
and documents contemplated to be executed and delivered by them pursuant to this Agreement
(this Agreement, the Debenture, the Guarantees, the Security Agreements and such other
agreements instruments and documents hereinafter collectively referred to as the
“Transaction Documents”); (b) issue the Consideration Shares; (c) issue the
Conversion Shares; and (d) to carry out the other provisions of the Transaction Documents. 

3 

        4.2
    Capitalization. All issued and outstanding shares of the Common Stock have been
duly authorized and validly issued and are fully paid and non-assessable. The issued and
outstanding capital stock of the Corporation and the Subsidiaries immediately prior to the
Closing are as set forth in section 4.2 of the Disclosure Schedule. Except as set forth in
section 4.2 of the Disclosure Schedule, there are no outstanding (or deemed outstanding)
options, warrants, convertible debentures, convertible instruments, agreements or other
rights to purchase or otherwise acquire upon conversion, exchange or otherwise from the
Corporation or any of the Subsidiaries any of their securities. The Consideration Shares,
when issued at the Closing, and the Conversion Shares when issued upon conversion of the
Debenture, will be duly authorized, validly issued and fully paid and non-assessable and
are not subject to any statutory, contractual or other first rights of refusal or other
preferential rights. 

        4.3
    Authorization; Binding Obligations. All corporate action on the part of the
Corporation and each Subsidiary, their officers, directors and shareholders necessary for
the authorization of the Transaction Documents and the performance of all of its
obligations thereunder and for the authorization, sale, issuance and delivery of the
Debenture, the Consideration Shares and the Conversion Shares have been taken or will be
taken prior to the Closing. The Conversion Shares have been or will be, prior to the
Closing, duly and validly reserved for issuance and, when issued upon conversion of the
Debenture will be validly issued, fully paid and non-assessable. The Corporation has taken
or will take all such action as may be necessary to assure that an adequate number of
shares of Common Stock is authorized and reserved for issuance of the Conversion Shares.
The Transaction Documents will, once executed, constitute, valid, legal and binding
obligations of the Corporation or the Subsidiary party thereto, as the case may be,
enforceable in accordance with their terms, except to such limitations as may result from
any applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws
relating to or affecting the enforcement of creditors’ rights generally. 

        4.4
    No Real Property. Neither the Corporation nor any Subsidiary owns any interest in
real estate, except properties leased or rented by the Corporation and its subsidiaries in
the ordinary course of its business. 

        4.5
    Consents and Approvals. Except as required by the Securities Act, or any state
securities laws, no filings with, notices to, or approvals of any governmental or
regulatory body are required to be obtained or made by the Corporation or any Subsidiary
in connection with the consummation of the transactions contemplated hereby. 

        4.6
    No Violations. The execution and delivery of the Transaction Documents and the
performance by the Corporation and the Subsidiary party thereto of their obligations
hereunder and thereunder (a) do not and will not conflict with or violate any provision of
the Corporation’s or such Subsidiary’s Articles of Incorporation or bylaws; and
(b) do not and will not (i) conflict with or result in a breach of the terms, conditions
or provisions of; (ii) constitute a default under; (iii) result in the creation of any
encumbrance upon the capital stock or assets of the Corporation or such Subsidiary
pursuant to; (iv) result in a violation of; or (iv) require any authorization, consent,
approval, exemption or other action by or notice to any court or administrative or
governmental body or other third party pursuant to, any law, statute, rule or regulation
or any agreement or instrument or any order, judgment or decree to which the Corporation
or such 

4 

Subsidiary is subject or by which any
of its assets are bound, except in each case where (A) the Corporation or such
Subsidiary has filed an applicable notice; (B) the Corporation or such Subsidiary has
obtained an appropriate waiver, consent or other authorization; or (C) such conflict,
violation, breach or default, or failure to obtain a consent or waiver, or failure to
provide notice may not reasonably be expected to have a material adverse effect on the
business, operations, financial condition or prospects of the Corporation or such
Subsidiary. 

        4.7
    Compliance with Laws. Except as disclosed in one or more of the Corporation’s
reports previously filed with the SEC (each, an “SEC Report”), the business of
the Corporation and each Subsidiary has been conducted in compliance with all applicable
laws and regulations of governmental authorities, except for such violations that have
been cured or that, individually or in the aggregate, may not reasonably be expected to
have a material adverse effect on the business, operations, financial condition or
prospects of the Corporation or such Subsidiary. Neither the real or personal properties
owned, leased, operated or occupied by the Corporation or such Subsidiary, nor the use,
operation or maintenance thereof (i) violates any applicable laws, or regulations of any
government or governmental authorities, or (ii) violates any restrictive or similar
covenant, agreement, commitment, understanding or arrangement, except where such violation
may not reasonably be expected to have a material adverse effect on the business,
operations, financial condition or prospects of the Corporation or such Subsidiary. 

        4.8
    Licenses; Permits; Related Approvals. The Corporation and each of the Subsidiaries
possess all licenses, permits, consents, approvals, authorizations, qualifications, and
orders (hereinafter collectively referred to as “Permits”) of all governments
and governmental authorities legally required to enable the Corporation or such Subsidiary
to conduct its business in all jurisdictions in which such business is conducted
(including without limitation all federal, state and local Permits relating to the
operation of funeral homes, crematoriums and related operations included in the
Corporation’s and the Subsidiaries’ business). Except as disclosed in one or
more of the SEC reports, all of the Permits are in full force and effect, and no
suspension, modification or cancellation of any of the Permits is pending or threatened,
which may reasonably be expected to have a material adverse effect on the business,
operations, financial condition or prospects of the Corporation or such Subsidiary. 

        4.9
    Title to Assets. Immediately following the Closing, the Corporation and each of the
Subsidiaries have good and marketable title to its property and assets free and clear of
all mortgages, security interests, liens, claims, and other encumbrances, except for
Permitted Encumbrances. With respect to the property and assets it leases, the Corporation
and each Subsidiary is in material compliance with such leases and, to its knowledge,
holds a valid leasehold interest free of any security interests, liens, claims, or other
encumbrances, except Permitted Encumbrances. “Permitted Encumbrances” means (a)
encumbrances for taxes, governmental charges, assessments or levies, provided, that
such taxes, governmental charges, assessments or levies are not yet due or are being
contested in good faith by appropriate proceedings; (b) deposits, encumbrances or pledges
to secure payments of workmen’s compensation, public liability, unemployment and
other similar insurance; (c) mechanics’, workmen’s, materialmen’s,
repairmen’s, warehousemen’s, vendors’ or carriers’ encumbrances, or
other similar encumbrances arising in the ordinary course of business consistent with past
practices and securing sums that are not past due or are being contested in good faith by
appropriate proceedings; (d) restrictions on transfers of securities imposed by United
States 

5 

federal, state or territorial
securities laws; (e) any encumbrance, right, lien, obligation or claim against any trust,
insurance policy, account, deposit, asset or other property held for the benefit or on
behalf of any purchaser or holder of rights under any contract, arrangement or similar
obligation of the Corporation or any Subsidiary for cremation services or merchandise; and
(f) other imperfections of title or encumbrances, if any, which imperfections of title or
other encumbrances do not materially impair the use of the assets to which they relate in
the business of the Corporation or the Subsidiaries, as applicable. 

        4.10
    Security Interests. Upon repayment of the CapEx Obligation, Holder will have a
valid and perfected first lien on the assets of the Corporation and each Subsidiary,
except for Permitted Encumbrances. 

        4.11
    Defaults. The Corporation and each of the Subsidiaries is not in default in the
performance, observance or fulfillment of any obligation, agreement, covenant, or
condition contained in any contract, indenture, mortgage, loan agreement, note, lease or
other instrument to which it is a party or by which it or any of its properties may be
bound, other than such violations or defaults that would not individually or in the
aggregate have a material adverse effect on the Corporation’s or such
Subsidiary’s business, prospects, properties, condition (financial or other), results
of operations or net worth. 

        4.12
    Intellectual Property. The Corporation and each of the Subsidiaries owns or has a
license to use all intellectual property used in its business. To the knowledge of the
Corporation, neither the Corporation nor any Subsidiary is infringing on any proprietary
right belonging to any other person, firm, or entity. The Corporation and each of the
Subsidiaries has the exclusive right and authority to use all of its creations and
inventions, trade secrets, processes, models, designs, software and formulas as are
necessary to enable the Corporation or such Subsidiary to conduct and to continue to
conduct all phases of its business in the manner presently conducted by it and in
accordance with the its business plan. To the knowledge of the Corporation, the
Corporation and each Subsidiary is the sole owner of the its trade secrets, free and clear
of any liens, encumbrances, restrictions, or legal or equitable claims of others and the
Corporation or such Subsidiary has taken all reasonable security measures to protect the
secrecy, confidentiality, and value of these trade secrets. To the knowledge of the
Corporation, the Corporation’s and the Subsidiaries’ intellectual property of a
proprietary nature is presently valid and protectible. 

        4.13
    Proprietary Rights. Except as otherwise disclosed in one or more SEC Reports,
neither the Corporation nor any Subsidiary has received any communications alleging that
it has violated or, by conducting its business as proposed would violate, any proprietary
rights of any other person, nor is the Corporation or any Subsidiary aware of any basis
for the foregoing. 

        4.14
    No Litigation. There is no action, suit or proceeding pending or, to the knowledge
of the Corporation, threatened against or affecting the Corporation, any of the
Subsidiaries or any of their properties or rights before any court or by or before any
governmental body or arbitration board or tribunal, and the Corporation and the
Subsidiaries are not in default with respect to any final judgment, writ, injunction,
decree, rule or regulation of any court or federal, state, local or other governmental
department, commission, board, bureau, agency or instrumentality, domestic or foreign. 

6 

        4.15
    Financial Projections. The Corporation has set forth under section 4.15 of the
Disclosure Schedule a true and correct copy of the Corporation’s financial
projections and budgets for the five (5) year period commencing January 1, 2004 (the
“Financial Projections”). The Financial Projections were prepared by management
in a manner consistent with the Corporation’s internal books and records and
financial projections prepared and used by management. To the best of the
Corporation’s knowledge, as of the date of this Agreement, the Financial Projections
accurately present and reflect the Corporation’s estimated financial projections and
anticipated results of operation for the periods covered in such Financial Projections
based on reasonable assumptions and estimates of management. 

        4.16
    Financial Statements; Undisclosed Liabilities. The Corporation has filed a true and
correct copies of (a) its audited combined balance sheet as of December 31, 2003 and
audited combined statement of operations and retained earnings and combined statements of
changes in financial position for the year ended December 31, 2003 with its annual SEC
Report on Form 10-KSB for the year ended December 31, 2003 and (b) its unaudited
consolidated balance sheet as of March 31, 2004, and unaudited consolidated statement of
operations and retained earnings and combined statement of changes in financial position
for the three month period ended March 31, 2004 with its quarterly SEC Report on Form
10-QSB for the quarter ended March 31, 2004 (hereinafter collectively referred to as the
“Financial Statements”). The Financial Statements are in accordance with the
books and records of the Corporation, are true, correct and complete and accurately
present the Corporation’s financial position as of the dates set forth therein and
the results of the Corporation’s operations and changes in the Corporation’s
financial position for the periods then ended, all in conformity with United States
generally accepted accounting principles applied on a consistent basis during each period
and on a basis consistent with that of prior periods. Except (i) as disclosed in the
Financial Statements; (ii) as disclosed in this Agreement; and (iii) as are incurred in
the ordinary course of the routine daily affairs of the Corporation’s and the
Subsidiaries’ business, neither the Corporation nor any of the Subsidiaries has any
liabilities or obligations of any nature or kind, known or unknown, whether accrued,
absolute, contingent, or otherwise. To the knowledge of the Corporation, there is no basis
for assertion against the Corporation or any of the Subsidiaries of any material claim,
liability or obligation not fully disclosed in the Financial Statements or in this
Agreement. 

        4.17
    Tax Matters. The Corporation and each of the Subsidiaries has duly and timely
filed, or obtained extensions of time for filing, all material tax returns required by
federal, state and local authorities (the “Returns”). All information reported
on the Returns is true, accurate, and complete. The Corporation is not a party to, and is
not aware of, any pending or threatened action, suit, proceeding, or assessment against it
for the collection of taxes by any government. The Corporation and each of the
Subsidiaries has paid in full all taxes, interest, penalties, assessments and deficiencies
owed by it to all taxing authorities. 

        4.18
    Full Disclosures. All factual information heretofore or herewith furnished by or on
behalf of the Corporation to the Purchaser for purposes of or in connection with this
Agreement or any transaction contemplated hereby (including the Corporation’s
business plan) is and all statements made by representatives of the Corporation in
connection with the negotiation of this Agreement do not contain any untrue statement of a
material fact or omit to state any material fact necessary to make the statements
contained herein not misleading. There is no fact known to the Corporation which
materially adversely affects the accuracy of the representations 

7 

and warranties contained in this
Agreement or the financial condition, operations, business, earnings, assets, or
liabilities of the Corporation or any of the Subsidiaries. 

5.     REPRESENTATIONS, WARRANTIES AND COVENANTS OF HOLDER 

        Holder
hereby represents, warrants and covenants to the Corporation as of the Closing Date: 

        5.1
    Requisite Power and Authority. Holder has all necessary power and authority to
execute and deliver the Transaction Documents and to carry out their provisions. All
actions on Holder’s part required for the lawful execution and delivery of the
Transaction Documents for which it has executed and delivered have been or will be
effectively taken prior to the Closing. 

        5.2
    Investment Representations. Holder understands that none of the Debenture, the
Consideration Shares and the Conversion Shares to be acquired by Holder have yet been
registered under the Securities Act. Holder also understands that the Debenture, the
Consideration Shares and the Conversion Shares to be acquired by Holder are being offered
and sold pursuant to an exemption from registration contained in regulations under the
Securities Act based in part upon Holder’s representations contained in this
Agreement. 

     
                
          (a)    Acquisition for Own Account. Holder is acquiring the Debenture,
          the Consideration Shares and/or the Conversion Shares to be acquired by Holder
          for its own account for investment only, and not with a view towards
          distribution in violation of applicable securities laws. 

     
                
          (b)    Accredited Investor. Holder represents that it is an
          “accredited investor” within the meaning of Rule 501(a) of Regulation
          D as promulgated under the Securities Act. 

     
                
          (c)    Non-Foreign Status. Holder is a nonresident alien for purposes of
          income taxation (as such term is defined in the Internal Revenue Code of 1986,
          as amended, and Income Tax Regulations). 

     
                
          (d)    Financial Experience. Holder has such knowledge and experience in
          financial and business matters as to be capable of evaluating the merits and
          risks of an investment the Debenture, the Consideration Shares and/or the
          Conversion Shares to be acquired by Holder (collectively, the
          “Securities”) and it is able to bear the economic risk of loss of its
          entire investment. 

     
                
          (e)    Information. The Corporation has provided to Holder the
          opportunity to ask questions and receive answers concerning the terms and
          conditions of the transactions contemplated in this Agreement and it has had
          access to such information concerning the Corporation as it has considered
          necessary or appropriate in connection with its investment decision to acquire
          the Securities. 

     
                
          (f)    Transfer Restrictions. Holder agrees that if it decides to offer,
          sell or otherwise transfer any of the Securities, it will not offer, sell or
          otherwise transfer any of such Securities directly or indirectly, unless: 

8 

     
                
      (1)    
          the sale is made pursuant to registration under the Securities Act; 

     
                
      (2)    
          the sale is made pursuant to the exemption from the registration requirements
          under the Securities Act provided by Rule 144 thereunder and in accordance with
          any applicable state securities or “Blue Sky” laws; or 

     
                
      (3)    
          the Securities are sold in a transaction that does not require registration
          under the Securities Act or any applicable state laws and regulations governing
          the offer and sale of securities, and it has prior to such sale furnished to the
          Corporation an opinion of counsel reasonably satisfactory to the Corporation. 

     
                
          (g)    Legends. Holder understands and agrees that the certificates
          representing the Securities will bear a legend stating that such shares have not
          been registered under the Securities Act or the securities laws of any state of
          the United States and may not be offered for sale or sold unless registered
          under the Securities Act and the securities laws of all applicable states of the
          United States or an exemption from such registration requirements is available. 

     
                
          (h)    Notations. Holder consents to the Corporation making a notation
          on its records or giving instructions to any transfer agent of the Corporation
          in order to implement the restrictions on transfer set forth and described
          herein. Each Debenture certificate will bear a legend to the following effect: 

	  	
“THE
SECURITIES REPRESENTED BY THIS DEBENTURE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933 (THE “ACT”) OR APPLICABLE STATE SECURITIES LAWS (THE “STATE
ACTS”), AND SHALL NOT BE SOLD, PLEDGED, HYPOTHECATED, DONATED, OR OTHERWISE
TRANSFERRED (WHETHER OR NOT FOR CONSIDERATION) BY THE HOLDER EXCEPT UPON THE ISSUANCE TO
THE CORPORATION OF A FAVORABLE OPINION OF HOLDER’S COUNSEL OR SUBMISSION TO THE
CORPORATION OF SUCH OTHER EVIDENCE AS MAY BE SATISFACTORY TO COUNSEL FOR THE CORPORATION,
TO THE EFFECT THAT ANY SUCH TRANSFER SHALL NOT BE IN VIOLATION OF THE ACT AND THE STATE
ACTS. HEDGING TRANSACTIONS INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE
CONDUCTED UNLESS IN COMPLIANCE WITH U.S. SECURITIES LAWS.” 

        Each
certificate representing Consideration Shares or Conversion Shares will bear a legend to
the following effect: 

	  	
“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”) OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES
AND SHALL NOT BE SOLD, PLEDGED, HYPOTHECATED, DONATED, OR OTHERWISE TRANSFERRED (WHETHER
OR NOT FOR CONSIDERATION) BY THE HOLDER UNLESS REGISTERED UNDER THE ACT OR EXCEPT UPON
THE ISSUANCE TO THE CORPORATION OF A  

9 

	  	
FAVORABLE
OPINION OF HOLDER’S COUNSEL OR SUBMISSION TO THE CORPORATION OF SUCH OTHER EVIDENCE
AS MAY BE SATISFACTORY TO COUNSEL FOR THE CORPORATION, TO THE EFFECT THAT ANY SUCH
TRANSFER SHALL NOT BE IN VIOLATION OF THE ACT AND THE STATE ACTS. HEDGING TRANSACTIONS
INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE
WITH U.S. SECURITIES LAWS.” 

     
                
          (i)    Due Diligence. Holder has been solely responsible for its own
          “due diligence” investigation of the Corporation, the Subsidiaries and
          their respective management, business and financial condition, for its own
          analysis of the merits and risks of this investment, and for its own analysis of
          the fairness and desirability of the terms of the investment; (ii) in taking any
          action or performing any role relative to the arranging of the proposed
          investment, the Holder has acted solely in its own interest; and (iii) neither
          the Holder nor any of its agents or employees has acted as an agent of the
          Corporation, or as an issuer, underwriter, broker, dealer or investment adviser
          relative to any security involved in this investment. 

     
                
          (j)    Tax Consequences. Holder understands and agrees that there may be
          material tax consequences to the Holder of an acquisition or disposition of the
          Debentures and/or the Consideration Shares. The Corporation gives no opinion and
          makes no representation with respect to the tax consequences to the Holder under
          United States, state, local or foreign tax law of the undersigned’s
          acquisition or disposition of such Debenture or Consideration Shares. 

     
                
          (k)    No Hedging. Holder will not, directly or indirectly, or through
          one or more intermediaries, maintain any short position in or engage in hedging
          transactions with regard to the Debenture, Consideration Shares or Conversion
          Shares except in compliance with the provisions of the Securities Act and
          applicable state securities laws. 

6.     CORPORATION COVENANTS 

        The
Corporation covenants and agrees with Holder that: 

        6.1
    Use of Proceeds. The Corporation shall use the proceeds from the sale of the
Debenture for the purposes of repaying in full the CapEx Obligation with such proceeds
being paid to CapEx and Bow River under escrow arrangements mutually agreeable to Holder
and the Corporation. The balance of the proceeds from the sale of the Debenture are to be
used for general corporate purposes. 

        6.2
    Reservation of Common Stock. The Corporation will reserve and keep available that
maximum number of its authorized but unissued Common Stock as may be required for the
issuance of the Conversion Shares. 

7.     HOLDER’S COVENANTS 

        Holder
covenants and agrees with the Corporation that upon Holder being repaid in full the amount
of Four Million Dollars ($4,000,000) owing under the Debenture (as such terms of repayment
are set forth in the Debenture), Holder will subordinate its first lien on the assets of
the Corporation and each Subsidiary, granted to Holder under the Transaction Documents, to
any 

10 

entity from which the Corporation
borrows money, provided, however, that the Corporation first obtains the consent of Holder
in accordance with Section 6.14 of the Debenture. 

8.     EXPENSE REIMBURSEMENTS 

        The
Corporation hereby agrees to reimburse Holder for all of its reasonable and documented
out-of-pocket expenses incurred in connection with the transactions contemplated hereby,
including all out-of-pocket expenses (including filing fees and other third party charges)
incurred in connection with its third party due diligence costs, and the preparation and
negotiation of the Transaction Documents. 

9.     MISCELLANEOUS 

        9.1
    Currency. Except as may be otherwise expressly provided, all dollar amounts herein
are references to United States dollars.  

        9.2
    Governing Law. This Agreement shall be governed by the internal law, and not the
law of conflicts, of the State of California  

        9.3
    Further Assurances: Each party to this Agreement covenants and agrees that, from
time to time prior to or subsequent to the Closing Date, it will, at the request and
expense of the requesting party, execute and deliver all such documents and do all such
other acts and things as any other party to this Agreement, acting reasonably, may from
time to time request be executed or done in order to better evidence or perfect or
effectuate the transactions contemplated in this Agreement. 

        9.4
    Survival. The representations, warranties, covenants and agreements made herein
shall survive any investigation made by or on behalf of Holder and the closing of the
transactions contemplated hereby. All statements as to factual matters contained in any
certificate or other instrument delivered by or on behalf of the Corporation pursuant
hereto in connection with the transactions contemplated hereby shall be deemed to be
representations and warranties by the Corporation hereunder solely as of the date of such
certificate or instrument. 

        9.5
    Successors and Assigns. Holder shall not be entitled to assign its rights under any
of the Transaction Documents, without the consent of the Corporation, which consent shall
not be unreasonably withheld or delayed; provided, however, that no such consent
shall be required for Holder to assign such rights to any person or group of persons
controlling or owning the majority of all beneficial interests of Holder, any other entity
controlled by such person or persons, or an entity controlled by Holder, provided that
such entity shall continue to be so controlled by such persons or Holder as applicable.
The provisions hereof shall inure to the benefit of, and be binding upon, the successors,
permitted assigns, heirs, executors and administrators of the parties hereto. 

        9.6
    Entire Agreement; Amendment and Waiver. The Transaction Documents expressly
delivered pursuant hereto or thereto supersede any other agreement, whether written or
oral, that may have been made or entered into by the parties hereto relating to the
matters contemplated hereby, and constitute the full and entire understanding and
agreement between the parties with regard to the subjects hereof and thereof, and no party
shall be liable or bound to any 

11 

other in any manner by any
representations, warranties, covenants and agreements except as specifically set forth or
incorporated by reference herein and therein. Neither the Transaction Documents, nor any
term thereof may be amended, waived, discharged or terminated except by a written
instrument signed by the Corporation and Holder. 

        9.7
    Severability. In case any provision of this Agreement shall be invalid, illegal or
unenforceable, the validity, legality and enforceability of the remaining provisions shall
not in any way be affected or impaired thereby. 

        9.8
    Notices. All notices required or permitted hereunder shall be in writing and shall
be deemed effectively given: (i) upon personal delivery to the party to be notified; (ii)
when sent by confirmed telex or facsimile if sent during normal business hours of the
recipient, if not, then on the next business day; (iii) five (5) days after having been
sent by registered or certified mail, return receipt requested, postage prepaid; or (iv)
one (1) business day after deposit with a nationally recognized overnight courier, special
next day delivery, with verification of receipt. All communications shall be sent: 

	  	
to the Corporation at:  

	  	
The Neptune Society, Inc.

4312 Woodman Avenue, Third Floor

Sherman Oaks, CA 91423

facsimile (818) 953-9844

Attention:  Marco Markin, President 

	  	
with a copy to:  

	  	
Dorsey & Whitney, LLP

1420 Fifth Avenue, Suite 3400

Seattle, WA  98101

facsimile (206) 903-8820

Attention:  Kenneth Sam 

	  	
to
Holder, at: 

	  	
Brooklyn Holdings LLC

P.O. Box 556

Charlestown, Nevis 

	  	
with
a copy to:  

	  	
Swidler Berlin Shereff Friedman, LLP

The Chrysler Building

405 Lexington Avenue

New York, NY 10174

facsimile:  (212) 891-9598 

12 

	  	
Attention: Morris Orens 

or at such other address as the
Corporation or Holder may designate by ten (10) days advance written notice to the other
parties hereto. 

        9.9
    Counterparts; Facsimile. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together shall
constitute one instrument. This Agreement may be executed and delivered by facsimile. 

        9.10
    Broker’s Fees. Each party hereto represents and warrants that no agent,
broker, investment banker, person or firm acting on behalf of or under the authority of
such party hereto is or will be entitled to any broker’s or finder’s fee or any
other commission directly or indirectly in connection with the transactions contemplated
herein. 

        IN
WITNESS WHEREOF, the parties hereto have executed this Agreement on the date first set
forth above. 

THE NEPTUNE SOCIETY, INC. 

THE NEPTUNE SOCIETY, INC. 

By:  
            
            
            
            

         Marco Markin

         Chief Executive Officer  

BROOKLYN HOLDINGS LLC:

By:  
            
            
            
            

         Authorized Representative:   

         Name:  

13 

EXHIBIT A 

DEBENTURE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}]]